Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients (English, HTML)

Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients: English HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-12-02

Canada’s health care system is complex and involves the participation of multiple stakeholders, who all have distinct roles in the planning and delivery of healthcare services. Health Canada’s decision-making role in approving a drug for marketing is distinct from the roles of those who make decisions about price-setting and public drug plan reimbursements.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data